<DOC>
	<DOCNO>NCT00398099</DOCNO>
	<brief_summary>To collect clinical response data use ertapenem approved indication .</brief_summary>
	<brief_title>To Evaluate Treatment Effect Anti-Infective Agent Different Kinds Infections ( 0826-052 )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Male female patient , 20 year age old Patients receive systemic antibiotic enrollment , patient fail clinical response ( improvement symptom laboratory data ) previous antibiotic treatment Patients require therapy prior identification cause infection Patient concomitant infection may interfere evaluation response ertapenem Patient apache ii &gt; 30 . Patient infection cause pathogen resistant ertapenem Patients know allergy ertapenem drug carbapenem class , beta lactams , lidocaine local anesthetic amide type The patient require antibiotic ertapenem ( : glycopeptides , macrolides antifungal agent )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>